Uni-Bio Science Group Announces 2023 Annual Results
- Written by Reporters
Record-breaking Revenue of HK$484.7M and Net Profit of HK$70.9M Pioneering Breakthroughs in Osteoporosis, Medical Aesthetics, and Ophthalmology Markets HONG KONG SAR - EQS Newswire - 27 March 2024 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred to as...
Read more: Uni-Bio Science Group Announces 2023 Annual Results